[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352254-105":3,"doc-detail-352254-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","theranostic-nanoparticles-in-prostate-cancer-disrupting-hypoxia-induced-glycolysis-by-targeting-hypoxia-inducible-factor-1-alpha-and-downstream-metabolites","Theranostic Nanoparticles in Prostate Cancer - Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites","","Prostate cancer is a major cause of cancer-associated death in men, with tumor hypoxia driving metabolic reprogramming toward glycolysis and contributing to treatment resistance. This review analyzes mechanisms linking hypoxia-induced glycolysis to prostate cancer aggressiveness and failure, emphasizing HIF-1α and downstream metabolites. It also evaluates theranostic nanoparticles that inhibit HIF-1α and metabolic targets while supporting imaging, tumor selectivity, and improved drug delivery, and discusses key translational barriers and future directions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/theranostic-nanoparticles-in-prostate-cancer-disrupting-hypoxia-induced-glycolysis-by-targeting-hypoxia-inducible-factor-1-alpha-and-downstream-metabolites/352254/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/theranostic-nanoparticles-in-prostate-cancer-disrupting-hypoxia-induced-glycolysis-by-targeting-hypoxia-inducible-factor-1-alpha-and-downstream-metabolites/352254.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does tumor hypoxia play in prostate cancer progression and therapy resistance?","Question",{"text":63,"@type":64},"Tumor hypoxia drives metabolic reprogramming, particularly a shift toward glycolysis, mediated largely by HIF-1α. This contributes to increased aggressiveness and treatment failure.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the main goal of theranostic nanoparticles described in the review?",{"text":68,"@type":64},"The review focuses on theranostic nanoparticles with dual actions: inhibiting HIF-1α and downstream metabolic targets, while enabling imaging and facilitating effective treatment.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is translation of these nanoparticle approaches still challenging?",{"text":72,"@type":64},"Translation is limited by biocompatibility concerns, regulatory complexity, and constraints related to scaling up manufacturing for clinical use.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352254,1790499008,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697",8,"Cancer Medicine  \nREVIEW  OPEN ACCESS   \nTheranostic Nanoparticles in Prostate Cancer: Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites  \nDaniel Ejim Uti1,2  | Wilson Achu Omang3 | Esther Ugo Alum1 | Inalegwu Bawa2 | Okechukwu Paul-Chima Ugwu1 | Ayodeji Oluwafemi Idowu4 | Item Justin Atangwho5 | Godwin Eneji Egbung5  \n1Department of Biochemistry, Research and Publications, Kampala International University, Kampala, Uganda | 2Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue State, Nigeria | 3Department of Medical Laboratory Sciences, College of Health Technology, Calabar, Nigeria | 4Department of Environmental Sciences, National Open University of Nigeria, Abuja,  \nNigeria | 5Faculty of Basic Medical Sciences, Department of Biochemistry, University of Calabar, Calabar, Nigeria Correspondence: Daniel Ejim Uti ([daniel.ejimuti@kiu.ac.ug](daniel.ejimuti@kiu.ac.ug), [dan4uti@gmail.com](dan4uti@gmail.com), [daniel.uti@fuhso.edu.ng](daniel.uti@fuhso.edu.ng))  \nReceived: 5 August 2025 | Revised: 23 October 2025 | Accepted: 16 December 2025  \nKeywords: glycolysis | HIF-1α | hypoxia | metabolic reprogramming | prostate cancer | theranostic nanoparticles | tumor microenvironment  \nABSTRACT  \nBackground: Prostate cancer (PCa) is a major cause of cancer-associated death in men. A crucial factor in its development and treatment resistance is tumor hypoxia, which drives metabolic reprogramming (especially reconfiguration towards glycolysis), mediated to a great extent by hypoxia-inducible factor-“HIF-1 alpha”(HIF-1a) .  \nAims: The present review summarizes (i) the mechanisms underlying hypoxia-induced glycolysis that enhances the aggressiveness of and treatment failure in PCa and (ii) recent developments in the field of theranostic nanoparticles (TNPs) with dual actions of inhibiting HIF-1a and downstream metabolic targets, while facilitating the imaging and treatment of the tumor. Materials and Methods: We summarize available evidence for the hypoxia-glycolysis signaling in PCa and assess nanotechnology achievable theranostic approaches (i.e., liposomal-, polymer-and metallic nanoplatforms) to promote drug delivery, real-time tumor picture and modulation of hypoxic tumor microenvironments.  \nResults: Hypoxia-inducible factor-1 alpha (HIF-1a) driven hypoxia is a common phenotypic feature that underlies the increased glycolysis and aggressive tumor phenotype. TNPs have been developed with the aim of (a) enhancing the drug bioavailability,(b) enabling the selectivity of tumor and imaging, and (c) reducing the hypoxia-linked metabolic pathways. The use of PCa as a model for TNP development is especially timely as hypoxia crosses the intersection of androgen receptor (AR) signaling heavens (hormone therapy resistance) leading to progression to castration-resistant PCa (CRPC) and as the Prostate-Specific Membrane Antigen (PSMA) is greatly overexpressed and is a validated target for custom imaging and treatment.  \nDiscussion: Compared with other hypoxia mediated solid tumors, hypoxia AR axis and PSMA overexpression have unique biological leverage for precision theranostics in PCa. Nevertheless, translation is limited by the issues of biocompatibility, complexities resulting from systematic regulations and constraints of scale-up manufacturing.  \nConclusion: TNPs are a promising platform to integrate diagnosis and treatment of PCa as they incorporate features of targeted delivery, on-line monitoring and interference with HIF-1a regulated glycolysis. Future advances will require interdisciplinary optimization, development of better tumor-targeting approaches, and artificial intelligence guided nanoparticle design to facilitate clinical scale up and regulation of technically and clinically acceptable theranostics of nanomedicines for PCa.  \nThis is an open access article under the terms of the Creative ","cbCaimTHgzfgR9Rp","https://ap.wps.com/l/cbCaimTHgzfgR9Rp","pdf",1441897,25,"English","# Abstract\n# Introduction\n## Global burden and risk factors\n## Treatment challenges and resistance","[{\"question\":\"What role does tumor hypoxia play in prostate cancer progression and therapy resistance?\",\"answer\":\"Tumor hypoxia drives metabolic reprogramming, particularly a shift toward glycolysis, mediated largely by HIF-1α. This contributes to increased aggressiveness and treatment failure.\"},{\"question\":\"What is the main goal of theranostic nanoparticles described in the review?\",\"answer\":\"The review focuses on theranostic nanoparticles with dual actions: inhibiting HIF-1α and downstream metabolic targets, while enabling imaging and facilitating effective treatment.\"},{\"question\":\"Why is translation of these nanoparticle approaches still challenging?\",\"answer\":\"Translation is limited by biocompatibility concerns, regulatory complexity, and constraints related to scaling up manufacturing for clinical use.\"}]","Theranostic Nanoparticles in Prostate Cancer - Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites | PDF",1790098567,63,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3044e9c3bafcd420cf770c9d1a96f320.webp",983,1291,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a104ae984f63829ece0be164272f0982.webp",982,1290,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c42346e9c78c94bb114db0b485afbcca.webp",981,1289,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffb5c2f4d61778b9cfd0505e740da184.webp",980,1287,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]